Inozyme Pharma, Inc. (INZY) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 6 Buy, 3 Hold.
The consensus price target is $4.00, representing an upside of 0% from the current price $4.00.
INZY Stock — 12-Month Price Forecast
$4.00
▲ +0.00% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Inozyme Pharma, Inc., the price target is $4.00.
The average price target represents a +0.00% change from the last price of $4.00.
INZY Analyst Ratings
Buy
Based on 9 analysts giving stock ratings to Inozyme Pharma, Inc. in the past 3 months
